Specialization, kinetics, and repertoire of type 1 interferon responses by human plasmacytoid predendritic cells

Blood
Tomoki ItoYong-Jun Liu

Abstract

Recent studies suggest plasmacytoid predendritic cells (pDCs) and myeloid dendritic cells (mDCs) have the functional plasticity to produce similar amounts of type 1 interferons (IFNs) and interleukin-12 (IL-12), challenging the concept and existence of DC subsets with distinct function. In this study, we demonstrate that previous studies showed human pDCs produce large amounts of IL-12 because of contaminating mDCs. Using highly purified human DC subsets, we found that although pDCs make 300 times more IFN-alpha than mDCs and mDCs make 13 times more IL-12 p70 than pDCs in response to all the toll-like receptor ligands and CD40 ligands, pDCs rapidly make large amounts of IFN-alpha within the first 12 hours of activation and become refractory to further stimulation. pDCs preferentially expressed the transcriptional factors critical for type 1 IFN, but not for IL-12 transcription, and they dedicated 60% of new transcriptional activity to make 19 type 1 IFN subtypes. This study provides formal proof that the plasticity of DC subsets is limited and that different DC subsets evolve to perform distinct functions in linking innate and adaptive immunity.

References

Dec 10, 1998·International Immunology·A SnijdersM L Kapsenberg
Nov 1, 2000·Proceedings of the National Academy of Sciences of the United States of America·S SanjabiS T Smale
Sep 7, 2001·The Journal of Allergy and Clinical Immunology·M Shodell, F P Siegal
Nov 20, 2001·Nature Immunology·C Asselin-PaturelG Trinchieri
Mar 27, 2002·Nature Reviews. Immunology·Ken Shortman, Yong-Jun Liu
Apr 24, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Veit HornungGunther Hartmann
Dec 7, 2002·Nature Immunology·Paul SheppardKevin M Klucher
Dec 14, 2002·Human Immunology·Andrzej DzionekJürgen Schmitz
Dec 17, 2002·Nature Immunology·Sergei V KotenkoRaymond P Donnelly
Feb 4, 2003·Nature Reviews. Immunology·Giorgio Trinchieri
May 8, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Lynn CorcoranKen Shortman
Jun 14, 2003·Clinical Immunology : the Official Journal of the Clinical Immunology Society·H C HeystekE C de Jong
Sep 10, 2003·Journal of Leukocyte Biology·Alexander IzaguirrePatricia Fitzgerald-Bocarsly
Feb 21, 2004·Science·Sandra S DieboldCaetano Reis e Sousa
Nov 19, 2004·Nature Immunology·Marco ColonnaYong-Jun Liu

❮ Previous
Next ❯

Citations

Mar 7, 2009·Journal of Clinical Immunology·Wei Cao
Jan 29, 2011·Current Allergy and Asthma Reports·Marek Jutel, Cezmi A Akdis
Nov 23, 2006·Nature Medicine·Jason M BrenchleyDaniel C Douek
Jul 22, 2008·Nature Reviews. Immunology·Michel GillietYong-Jun Liu
Mar 4, 2008·Proceedings of the National Academy of Sciences of the United States of America·Simona FiorentiniArnaldo Caruso
Jan 4, 2007·The Journal of Experimental Medicine·Tomoki ItoMichel Gilliet
Jan 23, 2013·The Journal of Experimental Medicine·Francesca PreteFederica Benvenuti
Jun 19, 2013·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Olivier DetournayEva Wattrang
Feb 28, 2008·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Stephanie M DillonCara C Wilson
Jan 21, 2010·Science Signaling·Kazuhiko ArimaYong-Jun Liu
Oct 7, 2006·American Journal of Respiratory Cell and Molecular Biology·Alexander FaithCatherine Hawrylowicz
Apr 3, 2008·The Journal of Clinical Investigation·Myron S CohenJoep Lange
Apr 16, 2010·Arthritis Research & Therapy·Angélica M Delgado-VegaSergey V Kozyrev
Feb 11, 2010·Journal of Leukocyte Biology·Patricia Fitzgerald-Bocarsly, Evan S Jacobs
Nov 4, 2009·Future Virology·Anna de LangBart L Haagmans
Jun 25, 2014·Molecular Therapy. Nucleic Acids·Kerstin KappBurghardt Wittig
Aug 26, 2010·Current Opinion in Allergy and Clinical Immunology·Mübeccel Akdis
Feb 18, 2016·Scientific Reports·Zhenyuan ZhouNan Shen
Sep 18, 2014·International Journal of Molecular Sciences·Juan P Mackern-ObertiAlexis M Kalergis
Mar 20, 2010·Autoimmunity·Silvano SozzaniAngela Tincani
Jul 16, 2015·Immunology·Juan P Mackern-ObertiAlexis M Kalergis
Nov 5, 2011·The Journal of Allergy and Clinical Immunology·Oscar PalomaresCezmi A Akdis
Apr 2, 2016·Journal of Immunology Research·Xiaofeng LiaoXin M Luo
Sep 14, 2010·Trends in Immunology·Ivan HirschDaniel Olive
Jul 3, 2010·Science China. Life Sciences·Fei TangYong-Jun Liu
Jun 29, 2010·Trends in Immunology·Silvano SozzaniFabio Facchetti
Mar 30, 2010·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Anne P LiaoSteven A Greenberg

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.